To include your compound in the COVID-19 Resource Center, submit it here.

Triangle Phase III Coviracil data

VIRS said that in a Phase III study (FTC-302) comparing its once daily Coviracil emtricitabine (FTC) nucleoside analog to twice daily Epivir

Read the full 226 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE